XML 125 R108.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Share-Based Compensation Share-Based Compensation - Restricted Stock and Performance Shares (Details) - $ / shares
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]    
Beginning balance, Weighted Average Grant Date Fair Value $ 21.87 $ 19.40
Ending balance, Weighted Average Grant Date Fair Value $ 22.23 $ 21.87
Restricted Stock [Member]    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]    
Beginning balance, Number of Share Units Outstanding 204  
Granted, Number of Share Units Outstanding 43  
Vested, Number of Share Units Outstanding 75  
Forfeited, Number of Share Units Outstanding (8)  
Ending balance, Number of Share Units Outstanding 164 204
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]    
Beginning balance, Weighted Average Grant Date Fair Value $ 57.57  
Granted, Weighted Average Grant Date Fair Value 71.56  
Vested, Weighted Average Grant Date Fair Value 42.21  
Forfeited, Weighted Average Grant Date Fair Value 67.58  
Ending balance, Weighted Average Grant Date Fair Value $ 67.73 $ 57.57
Performance Shares [Member]    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]    
Beginning balance, Number of Share Units Outstanding 143  
Granted, Number of Share Units Outstanding 58  
Net increase due to estimated performance, Number of Share Units Outstanding 16  
Vested, Number of Share Units Outstanding 82  
Forfeited, Number of Share Units Outstanding 0  
Ending balance, Number of Share Units Outstanding 135 143
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]    
Beginning balance, Weighted Average Grant Date Fair Value $ 62.08  
Granted, Weighted Average Grant Date Fair Value 71.98  
Net increase due to estimated performance, Weighted Average Grant Date Fair Value 66.20  
Vested, Weighted Average Grant Date Fair Value 59.77  
Ending balance, Weighted Average Grant Date Fair Value $ 68.23 $ 62.08